Forecast & RatingOnly 1 analyst currently covers Neuphoria Therapeutics (NEUP.US), with a price target of $7.00 and a rating of "Hold". The sample is very small, so treat this as a reference only. Data as of Jul 27, 2026; this does not constitute investment advice.
Jul 27, 2026Price forecast
$7.0091.26%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 25, 2026
Forecast met35.4%
Stock price$3.66
Avg. target$9.8
High target$20
Low target$2
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.